Subscription pull incentives—when countries pay yearly amounts to manufacturers for access to needed antibiotics—could help Canada have access to more new antibiotics and grow the pipeline as well.
Discusses the potential role of multiplex respiratory testing for SARS-CoV-2, influenza virus and RSV, and emerging issues related to highly pathogenic avian influenza virus.